Phase I Clinical Study of LNF2105 in Patients With Advanced Solid Tumors
Clinical trial NCT07661797 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07661797
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-06-01
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.